APAC March 2021 Headline News

Check out our most popular non-Japan stories in March 2021.

Asia-Pacific

Swisse and Biostime focus: H&H reveals global expansion drive for major brands as revenue grows 2.5%

NAD+ precursors: Hong Kong, ANZ and China help drive Chromadex results as firm fires warning over NMN explosion

Probiotics and CVD: OptiBiotix extends CholBiome range to APAC as blood pressure and cholesterol concerns rise

The Philippines

Immunity concerns: More than half of Filipino children deficient or insufficient in vitamin D - new population data

Australia

Toxicity tracking: New Australian data reveals vitamin and mineral cases rising by 9% per year

China

New formats get go-ahead in China: Regulator approves gummies and powders for health foods filing from June

Thailand

Hemp and CBD in Thailand: Food and supplement companies rush into NPD as FDA approves draft regulation

Singapore

Cool innovation: Singapore firm and academics create probiotic ice cubes